Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes
Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a…
23/02/2018 - 3 minutes
Intarcia
Swiss-US Partners Reveal New Candidate for Autoimmune Disease
Numab and Intarcia have a first candidate to combine a tri-specific antibody fragment with a…
15/09/2017 - 2 minutes
Fresh Cash for a Device that Can Treat Diabetes and Prevent HIV
Intarcia will develop a drug delivery device for HIV prevention that can significantly reduce dosing…
02/01/2017 - 2 minutes
Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.
Given the rates of diabetes reaching 'epidemic proportions', we figured it was time to have…
14/06/2016 - 9 minutes
Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases
Numab and Intarcia have achieved key milestones in the development of therapeutic antibody fragments. This…
06/06/2016 - 2 minutes
Servier to revolutionize Diabetes treatment thanks to Intarcia’s successful Phase III
Treatment of diabetes hasn't changed so much since the development of first human insulin by…
18/09/2015 - 3 minutes
Review: The Future of Biomarkers in Immuno-Oncology
Immuno-oncology is a Biotech field that is more than just hype - it could solve…
31/08/2015 - 5 minutes
Why do Servier bets one Billion euros on Revolutionary Diabetes Drugs Delivery Device?
The French company Servier wants to invest one billion euros by a partnering with the…
15/11/2014 - 2 minutes
